Moneycontrol PRO
LAMF
LAMF

Ayushman Kumar

Principal Correspondent, Editorial And Content, Moneycontrol

India to witness very high rise in adult and children obesity

INDIA

India to witness very high rise in adult and children obesity

Bristol Myers Squibb’s India centre to augment global drug development: Samit Hirawat

TRENDS

Bristol Myers Squibb’s India centre to augment global drug development: Samit Hirawat

Max Hospital surgeons successfully remove 4.5kg tumour shaped like football from patient's stomach

TRENDS

Max Hospital surgeons successfully remove 4.5kg tumour shaped like football from patient's stomach

Takeda working with Indian government, regulator to bring dengue vaccine

TRENDS

Takeda working with Indian government, regulator to bring dengue vaccine

Apple exploring use of tech sensors for detecting mental health problems: Sumbul Desai

TRENDS

Apple exploring use of tech sensors for detecting mental health problems: Sumbul Desai

Looking to make Hyderabad world’s 'health-tech Mecca': KTR

TRENDS

Looking to make Hyderabad world’s 'health-tech Mecca': KTR

Punjab govt converting Ayushman Bharat wellness centres into mohalla clinics: Health Ministry

TRENDS

Punjab govt converting Ayushman Bharat wellness centres into mohalla clinics: Health Ministry

Govt pharma body calls for banning e-pharmacies, alleges fake prescriptions by ghost doctors

TRENDS

Govt pharma body calls for banning e-pharmacies, alleges fake prescriptions by ghost doctors

Zydus, Medtronic partner for first AI-based stroke care network in Gujarat

TRENDS

Zydus, Medtronic partner for first AI-based stroke care network in Gujarat

Biocon aims to become the largest biosimilar company globally: Kiran Mazumdar-Shaw

TRENDS

Biocon aims to become the largest biosimilar company globally: Kiran Mazumdar-Shaw

Allowing greater tax deductions can fuel innovation in pharma sector: Biocon's Kiran Mazumdar-Shaw

TRENDS

Allowing greater tax deductions can fuel innovation in pharma sector: Biocon's Kiran Mazumdar-Shaw

Exclusive | Pharma manufacturing needs a robust regulatory system: Kiran Mazumdar-Shaw

TRENDS

Exclusive | Pharma manufacturing needs a robust regulatory system: Kiran Mazumdar-Shaw

Why DCGI served a show-cause notice on e-pharmacies

TRENDS

Why DCGI served a show-cause notice on e-pharmacies

Tata 1mg, Flipkart, Amazon among 20 e-pharmacies served DGCI notice for violating drug rules

TRENDS

Tata 1mg, Flipkart, Amazon among 20 e-pharmacies served DGCI notice for violating drug rules

Tata1mg focusing on expansion in Tier 3 cities, working to reduce delivery time; says CTO Gaurav Agarwal

TRENDS

Tata1mg focusing on expansion in Tier 3 cities, working to reduce delivery time; says CTO Gaurav Agarwal

Is uniform implementation of drug approval system a possibility in India?

TRENDS

Is uniform implementation of drug approval system a possibility in India?

Online doctor consultations in non-metros grew 87% in 2022: Report

TRENDS

Online doctor consultations in non-metros grew 87% in 2022: Report

Centre incentivizing R&D a positive step to encourage investment in innovation, says C.S. Muralidharan of Sun Pharma

TRENDS

Centre incentivizing R&D a positive step to encourage investment in innovation, says C.S. Muralidharan of Sun Pharma

Akums gets DCGI nod to launch drug for uncontrolled diabetes in India

TRENDS

Akums gets DCGI nod to launch drug for uncontrolled diabetes in India

Merge state, central drug regulators for better standards: Bharat Biotech chairman

TRENDS

Merge state, central drug regulators for better standards: Bharat Biotech chairman

Chennai firm asked to halt production of eye drops linked to vision loss, death in US

HEALTH

Chennai firm asked to halt production of eye drops linked to vision loss, death in US

Will bring new treatment options in prostate, breast and renal cancers, says Glenmark’s Alok Malik

TRENDS

Will bring new treatment options in prostate, breast and renal cancers, says Glenmark’s Alok Malik

Max Healthcare Q3 profit rises 7% to Rs 269 crore

TRENDS

Max Healthcare Q3 profit rises 7% to Rs 269 crore

Pharma industry hails budget’s 'positive thrust on research, innovation'

BUSINESS

Pharma industry hails budget’s 'positive thrust on research, innovation'

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347